Staging disease severity in pathologically confirmed cases of frontotemporal dementia

Neurology

Volumn 60, Issue 6, 2003, Pages 1005-1011

  Broe, M ^a   Hodges, J R ^b   Schofield, E ^c   Shepherd, C E ^a   Kril, J J ^a   Halliday, Glenda M ^c,d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b MRC COGNITION AND BRAIN SCIENCES UNIT   (United Kingdom)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATROPHY; BASAL GANGLION; BRAIN SLICE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FRONTAL LOBE; FRONTOTEMPORAL DEMENTIA; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; NONPARAMETRIC TEST; PRIORITY JOURNAL; REPRODUCIBILITY; STAGING; TEMPORAL CORTEX; VALIDATION PROCESS;

EID: 0037465770     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000052685.09194.39     Document Type: Article

References (32)

1. Ratnavalli E, Brayne C, Dawson K, Hodges JR. The prevalence of frontotemporal dementia. Neurology 2002;58:1615-1621.
2. McKhann GM, Albert MS, Grossman M, Miller BL, Dickson DW, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia: report of the work group on frontotemporal dementia and Pick's disease. Arch Neurol 2001;58:1803-1809.
3. Hodges JR, Miller BL. The classification, genetics and neuropathology of frontotemporal dementia. Introduction to the special topic papers: part 1. Neurocase 2001;7:31-35.
4. Snowden JS, Neary D, Mann DMA. Fronto-temporal lobar degeneration: fronto-temporal dementia, progressive aphasia, semantic dementia. New York: Churchill Livingstone, 1996.
5. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EPJ. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985;44:559-577.
6. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
7. Broe M, Shepherd C, Milward E, Halliday G. Relationship between DNA fragmentation, morphological changes and neuronal loss in Alzheimer's disease and dementia with Lewy bodies. Acta Neuropathol 2001;101:616-624.
8. The National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 1997;18(suppl 4):S1-S2.
9. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
10. Dickson DW. Neuropathological differentiation of progressive supranu-clear palsy and corticobasal degeneration. J Neurol 1999;246(suppl 2):116-115.
11. Lantos P. Neuropathological diagnostic criteria of multiple system atrophy: a review. In: Cruz-Sanchez FF, Ravid R, Cuzner ML, eds. Neuropathological diagnostic criteria for brain banking. Amsterdam: IOS Press, 1995.
12. Neary D, Snowden JS, Mann DMA. Classification and description of frontotemporal dementias. Ann NY Acad Sci 2000;920:46-51.
13. Bak TH, Hodges JR. Motor neurone disease, dementia and aphasia: coincidence, co-occurrence or continuum? J Neurol 2001;248:260-270.
14. Mathuranath PS, Xuereb JH, Bak T, Hodges JR. Corticobasal ganglionic degeneration and/or frontotemporal dementia? A report of two overlap cases and review of literature. J Neurol Neurosurg Psychiatry 2000;68:304-312.
15. Wenning GK, Ebersbach G, Verny M, et al. Progression of falls in postmortem-confirmed parkinsonian disorders. Mov Disord 1999;14:947-950.
16. Litvan I, Agid Y, Goetz C, et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology 1997;48:119-125.
17. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
18. Fleiss JL. Measuring nominal scale agreement among many raters. Psychol Bull 1971;76:378-382.
19. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
20. Mann DMA, South PW. The topographic distribution of brain atrophy in frontal lobe dementia. Acta Neuropathol 1993;85:334-340.
21. Mummery CJ, Patterson K, Price CJ, Ashburner J, Frackowiak RS, Hodges JR. A voxel-based morphometry study of semantic dementia: relationship between temporal lobe atrophy and semantic memory. Ann Neurol 2000;47:36-45.
22. Rosen HJ, Gorno-Tempini ML, Goldman WP, et al. Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology 2002;58:198-208.
23. Galton CJ, Gomez-Anson B, Antoun N, et al. Temporal lobe rating scale: application to Alzheimer's disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry 2001;70:165-173.
24. Ashford JW, Shan M, Butler S, Rajasekar A, Schmitt FA. Temporal quantification of Alzheimer's disease severity: "time-index" model. Dementia 1995;6:269-280.
25. Mitnitski AB, Graham JE, Mogilner AJ, Rockwood K. The rate of decline in function in Alzheimer's disease and other dementias. J Gerontol A Biol Sci Med Sci 1999;54:M65-M69.
26. Knopman DS, Berg JD, Thomas R, Grundman M, Thal LJ, Sano M. Nursing home placement is related to dementia progression: experience from a clinical trial. Alzheimer's Disease Cooperative Study. Neurology 1999;52:714-718.
27. Hebert R, Dubois B, Wolfson C, Chanmbers L, Cohen C. Factors associated with long-term institutionalization of older people with dementia: data from the Canadian Study of Health and Aging. J Gerontol A Biol Sci Med Sci 2001;56:M693-M699.
28. Heyman A, Peterson B, Fillenbaum G, Pieper C. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part XIV: demographic and clinical predictors of survival in patients with Alzheimer's disease. Neurology 1996;46:656-660.
29. Varma AR, Adams W, Lloyd JJ, et al. Diagnostic patterns of regional brain atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia. Acta Neurol Scand 2002;105:261-269.
30. Minoshima S, Cross DJ, Foster NL, Henry TR, Kuhl DE. Discordance between traditional pathologic and energy metabolic changes in early Alzheimer's disease. Pathophysiological implications. Ann NY Acad Sci 1999;893:350-352.
31. Johnson KA, Jones K, Holman BL, et al. Preclinical prediction of Alzheimer's disease using SPECT. Neurology 1998;50:1563-1571.
32. Reiman EM, Caselli RJ, Yun LS, et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the ε4 allele for apolipoprotein E. N Engl J Med 1996;334:752-758.